NASDAQ: MTVAMetavia Inc Stock Ownership - Who owns Metavia?
Insider buying vs selling
Have Metavia Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Marshall H. Woodworth | Chief Financial Officer | 2025-06-04 | 14,200 | $0.70 | $9.94kBuy |
| Donga St Co Ltd | 10% Owner | 2025-05-08 | 4,647,887 | $0.71 | $3.30MBuy |
| Hyung Heon Kim | CEO President | 2025-03-01 | 2,795 | $1.46 | $4.08kSell |
| Marshall H. Woodworth | Chief Financial Officer | 2025-03-01 | 3,417 | $1.46 | $4.99kSell |
MTVA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MTVA insiders and whales buy or sell their stock.
MTVA Shareholders
What type of owners hold Metavia Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Donga St Co Ltd | 454.07% | 9,995,679 | $18.59M | Insider |
| Na Yeon Kim | 280.67% | 6,178,535 | $11.49M | Insider |
| Einvestment Inc | 273.32% | 6,016,669 | $11.19M | Insider |
| Jeong Gyun Oh | 93.48% | 2,057,893 | $3.83M | Insider |
| Charles Phd Bisgaier | 65.89% | 1,450,362 | $2.70M | Insider |
| Steven R. Phd Gullans | 55.89% | 1,230,252 | $2.29M | Insider |
| Goldman Sachs Group Inc | 55.44% | 1,220,502 | $2.27M | Insider |
| Akash Bakshi | 41.48% | 913,085 | $1.70M | Insider |
| David Lowenschuss | 36.63% | 806,247 | $1.50M | Insider |
| Jk Biopharma Solutions Inc | 36.35% | 800,170 | $1.49M | Insider |
MTVA vs Biotech Stocks
Metavia Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.